Back to trial details

Intake questionnaire

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Applying to The University of Texas M. D. Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Solid Tumor, Adult?
3. Are you able to travel to Houston for study visits?